LncRNA miR663AHG represses the development of colon cancer in a miR663a-dependent manner
暂无分享,去创建一个
D. Deng | Jing Zhou | L. Gu | Yantao Du | Wei-ping Tian | Qianwen Ren | Hongfan Yuan | Yuwan Ma
[1] D. Deng,et al. TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern , 2022, Oncogene.
[2] Ningjing Song,et al. Long non-coding RNA RP11-342L8.2, derived from RNA sequencing and validated via RT-qPCR, is upregulated and correlates with disease severity in psoriasis patients , 2022, Irish Journal of Medical Science (1971 -).
[3] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[4] L. Luo,et al. SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback. , 2021, Cancer letters.
[5] Rui Wang,et al. Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression , 2021, Cell Death & Disease.
[6] Yixuan Hou,et al. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties , 2021, Journal of Hematology & Oncology.
[7] G. Hu,et al. Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63 , 2021, Nature Communications.
[8] Juze Yang,et al. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC , 2021, Journal of Hematology & Oncology.
[9] Yanyong Yang,et al. Long non-coding RNA ANRIL promotes homologous recombination-mediated DNA repair by maintaining ATR protein stability to enhance cancer resistance , 2021, Molecular Cancer.
[10] J. Saiz,et al. Right‐sided non‐recurrent laryngeal nerve without any vascular anomaly: an anatomical trap , 2021, ANZ journal of surgery.
[11] Ming Li,et al. Prediction of a Potential Mechanism of Intervertebral Disc Degeneration Based on a Novel Competitive Endogenous RNA Network , 2021, BioMed research international.
[12] Xian Shen,et al. Long noncoding RNAs: functions and mechanisms in colon cancer , 2020, Molecular Cancer.
[13] Aimin Li,et al. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling , 2020, Journal of Experimental & Clinical Cancer Research.
[14] X. Shang,et al. Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets , 2020, PeerJ.
[15] Aimin Li,et al. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling , 2020, Journal of experimental & clinical cancer research : CR.
[16] D. Deng,et al. Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells , 2020, Molecular Cancer.
[17] M. Dianatpour,et al. CRISPR/Cas9-mediated knockout of MLL5 enhances apoptotic effect of cisplatin in HeLa cells in vitro , 2020, EXCLI journal.
[18] Christopher D. Brown,et al. The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.
[19] Zemin Zhang,et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..
[20] Senlin Zhao,et al. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility , 2019, EBioMedicine.
[21] D. Deng,et al. miR663a-TTC22V1 axis inhibits colon cancer metastasis , 2019, Oncology reports.
[22] Guoqing Zhang,et al. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma , 2018, BMC Cancer.
[23] D. Deng,et al. MALAT1–miR663a negative feedback loop in colon cancer cell functions through direct miRNA–lncRNA binding , 2018, Cell Death & Disease.
[24] E. Tili,et al. MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol , 2018, Medicines.
[25] T. Yeatman,et al. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling , 2017, Nature Medicine.
[26] P. Nangia-Makker,et al. A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells , 2017, Molecular Cancer.
[27] Ming Sun,et al. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer , 2017, Molecular Cancer.
[28] M. Krstic-Demonacos,et al. miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway , 2017, BMC Cancer.
[29] J. Beermann,et al. Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. , 2016, Physiological reviews.
[30] T. Gabaldón,et al. Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer , 2016, Front. Genet..
[31] You-hong Cui,et al. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma , 2015, Clinical Cancer Research.
[32] Runsheng Chen,et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. , 2015, Cell stem cell.
[33] Shenghao Xu,et al. Supplementary Information , 2014, States at War, Volume 3.
[34] Yongwei Yu,et al. miR‐663 Induces Castration‐Resistant Prostate Cancer Transformation and Predicts Clinical Recurrence , 2014, Journal of cellular physiology.
[35] Pavel Vodicka,et al. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. , 2014, Carcinogenesis.
[36] Jian Lu,et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. , 2013, The Lancet. Oncology.
[37] David A. Scott,et al. Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.
[38] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[39] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[40] J. Yun,et al. MiR-663, a microRNA targeting p21WAF1/CIP1, promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma , 2012, Oncogene.
[41] Nadav S. Bar,et al. Landscape of transcription in human cells , 2012, Nature.
[42] C. Croce,et al. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. , 2010, Biochemical pharmacology.
[43] C. Croce,et al. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. , 2010, Carcinogenesis.
[44] B. Cullen,et al. The imprinted H19 noncoding RNA is a primary microRNA precursor. , 2007, RNA.
[45] Qian Liu,et al. A high-throughput method to monitor the expression of microRNA precursors. , 2004, Nucleic acids research.
[46] Jacob D. Jaffe,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[47] X. Li,et al. Transcriptional regulation of mammalian miRNA genes. , 2011, Genomics.